Výsledky vyhledávání - "Molecular Targeted Therapy/methods"
-
1
Autoři: a další
Zdroj: Sci Rep
Sa-Nguansai, S, Rattanasiri, S, Pornsuriyasak, P, Numthavaj, P, McKay, G J, Attia, J & Thakkinstian, A 2025, 'A network meta-analysis of efficacy and safety of adjuvant targeted therapy or immunotherapy in non-small cell lung cancer', Scientific Reports, vol. 15, 21696. https://doi.org/10.1038/s41598-025-05823-2Témata: Treatment Outcome, Protein Kinase Inhibitors/therapeutic use, Carcinoma, Non-Small-Cell Lung/drug therapy, ErbB Receptors/antagonists & inhibitors, Immunotherapy/methods, Humans, Network Meta-Analysis as Topic, name=SDG 3 - Good Health and Well-being, Lung Neoplasms/drug therapy, Molecular Targeted Therapy/methods, Article, Chemotherapy, Adjuvant/methods, Randomized Controlled Trials as Topic
Popis souboru: application/pdf
Přístupová URL adresa: https://pure.qub.ac.uk/en/publications/470fbca2-94a7-49b8-b0ba-5e3fafed2560
-
2
Autoři: a další
Zdroj: Rask Lage-Hansen, P, Svendsen, N, Kirkham, J, Mai Nielsen, S, Amris, K, de Wit, M, Boers, M, Ellingsen, T & Christensen, R 2024, 'Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set', Ann Rheum Dis, vol. 83, no. 10, pp. 1288-1294.
Témata: Biological Products, Health Care/methods, Outcome Assessment, Endpoint Determination, Arthritis, Antirheumatic Agents/therapeutic use, Patient Reported Outcome, Severity of Illness Index, Rheumatoid/drug therapy, Biological Therapy, Health Care, Arthritis, Rheumatoid, 03 medical and health sciences, Treatment Outcome, 0302 clinical medicine, Rheumatoid, Antirheumatic Agents, Outcome Assessment, Health Care, Humans, Patient Reported Outcome Measures, Molecular Targeted Therapy, Biological Products/therapeutic use, Molecular Targeted Therapy/methods, Randomized Controlled Trials as Topic
-
3
Autoři: a další
Přispěvatelé: a další
Zdroj: American Journal of Clinical Dermatology. 25:735-764
Témata: Skin/pathology, Biological Products, Quality of Life, Piperidines/therapeutic use, Lichen Planus, Pyrimidines/therapeutic use, Phosphodiesterase 4 Inhibitors/therapeutic use, Janus Kinase Inhibitors/therapeutic use, Thalidomide, Pyrimidines, Piperidines, Lichen Planus/diagnosis/therapy/drug therapy, Thalidomide/analogs & derivatives/therapeutic use, Humans, Janus Kinase Inhibitors, Phosphodiesterase 4 Inhibitors, Molecular Targeted Therapy, Biological Products/therapeutic use, Molecular Targeted Therapy/methods, Skin
Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38982032
-
4
Autoři:
Zdroj: Advances in Experimental Medicine and Biology ISBN: 9783031708749
Howell, S J & Howell, A 2025, Targeting Oestrogen Receptor Signalling in Breast Cancer Therapy. in A Guide to Breast Cancer Research : From Cellular Heterogeneity and Molecular Mechanisms to Therapy. Advances in Experimental Medicine and Biology, vol. 1464, Springer Nature, pp. 449-474. https://doi.org/10.1007/978-3-031-70875-6_22Témata: Selective Estrogen Receptor Modulators, Antineoplastic Agents, Hormonal/therapeutic use, Antineoplastic Agents, Hormonal, Aromatase Inhibitors, Antineoplastic Agents, Breast Neoplasms, Breast Neoplasms/drug therapy, Estrogen Receptor Antagonists/therapeutic use, Receptors, Estrogen, Signal Transduction/drug effects, Selective Estrogen Receptor Modulators/therapeutic use, Receptors, Humans, Animals, Female, Estrogen/metabolism, Receptors, Estrogen/metabolism, Hormonal/therapeutic use, Molecular Targeted Therapy/methods, Aromatase Inhibitors/therapeutic use, Signal Transduction
-
5
Autoři: a další
Zdroj: Clin Exp Metastasis
Clinical and Experimental MetastasisTémata: 0301 basic medicine, ddc:610, 0303 health sciences, Antineoplastic Agents, Review, Medicine & health, 3. Good health, 03 medical and health sciences, Hyaluronan Receptors, Neoplasms, Humans, Animals, Molecular Targeted Therapy, Neoplasm Metastasis, Cancer, Pleiotropicity, Humans [MeSH], Metastasis, Neoplasm Metastasis [MeSH], Hyaluronan Receptors/metabolism [MeSH], Antineoplastic Agents/pharmacology [MeSH], Animals [MeSH], Neoplasms/metabolism [MeSH], Neoplasms/pathology [MeSH], CD44, Antineoplastic Agents/therapeutic use [MeSH], Co-receptors, Signal Transduction [MeSH], Molecular Targeted Therapy/methods [MeSH], Signal Transduction
Popis souboru: application/pdf
-
6
Autoři: a další
Zdroj: Arch Gynecol Obstet
Témata: Male, Adult, Aged, 80 and over, 0301 basic medicine, Aminopyridines, Antineoplastic Agents, Gynecologic Oncology, Middle Aged, Poly(ADP-ribose) Polymerase Inhibitors, Breast Neoplasms, Male/drug therapy [MeSH], monarchE, Aged, 80 and over [MeSH], Aged [MeSH], Purines [MeSH], Adult [MeSH], Humans [MeSH], Aminopyridines/therapeutic use [MeSH], OlympiA, Male breast cancer, Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use [MeSH], CDK 4/6 inhibitors, Middle Aged [MeSH], Feasibility Studies [MeSH], NATALEE, Chemotherapy, Adjuvant [MeSH], Male [MeSH], Systemic therapy, Benzimidazoles/therapeutic use [MeSH], Antineoplastic Agents/therapeutic use [MeSH], Benzimidazoles/administration, Molecular Targeted Therapy/methods [MeSH], Registries [MeSH], Breast Neoplasms, Male, 03 medical and health sciences, 0302 clinical medicine, Chemotherapy, Adjuvant, Purines, Humans, Feasibility Studies, Benzimidazoles, Registries, Molecular Targeted Therapy, Aged
Popis souboru: pdf
Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38472501
https://repository.publisso.de/resource/frl:6523133 -
7
Autoři:
Zdroj: Shan , L & Swaab , D F 2025 , ' Histamine 2 receptor : Emerging target for the treatment of attention-deficit/hyperactivity disorder ' , Cell reports. Medicine , vol. 6 , no. 3 , pp. 102023 . https://doi.org/10.1016/j.xcrm.2025.102023
Témata: Attention Deficit Disorder with Hyperactivity/metabolism, Humans, Receptors, Histamine H2/metabolism, Histamine/metabolism, Animals, Molecular Targeted Therapy/methods
Popis souboru: application/pdf
-
8
Autoři: a další
Přispěvatelé: a další
Zdroj: Med Oncol
Témata: Brain Neoplasms/genetics, Original Paper, Clinical Trials as Topic, Brain Neoplasms, Molecular testing, Glioblastoma/genetics, Clinical trial, SDG 3 - Good Health and Well-being, Targeted treatment, Recurrent glioblastoma, Journal Article, Biomarkers, Tumor, Humans, Molecular Targeted Therapy, Genome-driven oncology, Biomarkers, Tumor/genetics, Neoplasm Recurrence, Local/genetics, Neoplasm Recurrence, Local, Glioblastoma, Molecular Targeted Therapy/methods
Popis souboru: application/pdf
-
9
Autoři: a další
Zdroj: Oncologist
The oncologist, vol. 30, no. 2
Oncologist, vol 30, iss 2Témata: clinical decision-making, controversies, Tumor, Lung Neoplasms, Carcinoma, Lung Cancer, lung cancer diagnosis, unanswered questions, lung cancer treatment, Humans, Lung Neoplasms/therapy, Lung Neoplasms/pathology, Lung Neoplasms/genetics, Carcinoma, Non-Small-Cell Lung/therapy, Carcinoma, Non-Small-Cell Lung/genetics, Carcinoma, Non-Small-Cell Lung/pathology, Immunotherapy/methods, ErbB Receptors/genetics, Mutation, Molecular Targeted Therapy/methods, Biomarkers, Tumor/genetics, lung cancer management, ErbB Receptors, Carcinoma, Non-Small-Cell Lung, Biomarkers, Tumor, Immunotherapy, Molecular Targeted Therapy, Non-Small-Cell Lung, Biomarkers
Popis souboru: application/pdf
Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39237103
https://serval.unil.ch/notice/serval:BIB_A6408ED80877
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_A6408ED808779
https://serval.unil.ch/resource/serval:BIB_A6408ED80877.P001/REF.pdf
https://escholarship.org/uc/item/0n07x907
https://escholarship.org/content/qt0n07x907/qt0n07x907.pdf -
10
Autoři: a další
Zdroj: Target Oncol
Témata: Proto-Oncogene Proteins p21(ras), Pancreatic Neoplasms, Mutation, Humans, Pancreatic Neoplasms [MeSH], Pancreatic Neoplasms/genetics [MeSH], Medical and Health Sciences, Mutation [MeSH], Humans [MeSH], Original Research Article, Precision Medicine/methods [MeSH], Retrospective Studies [MeSH], Molecular Targeted Therapy/methods [MeSH], Pancreatic Neoplasms/drug therapy [MeSH], Proto-Oncogene Proteins p21(ras)/genetics [MeSH], Molecular Targeted Therapy, Precision Medicine, 3. Good health, Retrospective Studies
-
11
Autoři: a další
Přispěvatelé: a další
Zdroj: Nat Commun
Nature Communications, Vol 15, Iss 1, Pp 1-21 (2024)
TRACERx Consortium 2024, 'Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling', Nature Communications, vol. 15, no. 1, 4871. https://doi.org/10.1038/s41467-024-47606-9
Hobor, S, Al Bakir, M, Hiley, C T, Skrzypski, M, Frankell, A M, Bakker, B, Watkins, T B K, Markovets, A, Dry, J R, Brown, A P, van der Aart, J, van den Bos, H, Spierings, D, Oukrif, D, Novelli, M, Chakrabarti, T, Rabinowitz, A H, Ait Hassou, L, Litière, S, Kerr, D L, Tan, L, Kelly, G, Moore, D A, Renshaw, M J, Venkatesan, S, Hill, W, Huebner, A, Martínez-Ruiz, C, Black, J R M, Wu, W, Angelova, M, McGranahan, N, Downward, J, Chmielecki, J, Barrett, C, Litchfield, K, Chew, S K, Blakely, C M, de Bruin, E C, Foijer, F, Vousden, K H, Bivona, T G & TRACERx Consortium 2024, 'Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling', Nature Communications, vol. 15, no. 1, 4871. https://doi.org/10.1038/s41467-024-47606-9
Nature CommunicationsTémata: Male, Lung Neoplasms/genetics, Lung Neoplasms, DNA Copy Number Variations, ErbB Receptors/genetics, Science, Drug Resistance, Adenocarcinoma of Lung, Adenocarcinoma of Lung/genetics, Article, Cell Line, Mice, Chromosomal Instability, Cell Line, Tumor, Humans, Animals, Molecular Targeted Therapy, Protein Kinase Inhibitors, Tumor, Neoplasm/genetics, Drug Resistance, Neoplasm, ErbB Receptors, Female, Mutation, Tumor Suppressor Protein p53, Tumour Biology, 3. Good health, Protein Kinase Inhibitors/pharmacology, Neoplasm, Tumor Suppressor Protein p53/genetics, Genetics & Genomics, Molecular Targeted Therapy/methods
Popis souboru: application/pdf; Electronic
Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38871738
https://doaj.org/article/a58c4b29e1d8491b8078212067633916
https://research.manchester.ac.uk/en/publications/45ea8e60-84a7-4878-8117-06b85496738f
https://doi.org/10.1038/s41467-024-47606-9
https://research.rug.nl/en/publications/38b96596-73c5-4c15-b965-3b7f9c8e86b4
https://hdl.handle.net/11370/38b96596-73c5-4c15-b965-3b7f9c8e86b4
https://doi.org/10.1038/s41467-024-47606-9
https://cris.maastrichtuniversity.nl/en/publications/259572d1-9fc1-4588-bf24-832539b624d8
https://doi.org/10.1038/s41467-024-47606-9
https://research.manchester.ac.uk/en/publications/45ea8e60-84a7-4878-8117-06b85496738f
http://www.scopus.com/inward/record.url?scp=85196137928&partnerID=8YFLogxK
https://doi.org/10.1038/s41467-024-47606-9
http://www.scopus.com/inward/record.url?scp=85196137928&partnerID=8YFLogxK
https://doi.org/10.1038/s41467-024-47606-9
https://pure.au.dk/portal/en/publications/ef39974b-394b-4e23-a349-8445d00d9fe6 -
12
Autoři: a další
Zdroj: World J Surg Oncol
World Journal of Surgical Oncology, Vol 22, Iss 1, Pp 1-10 (2024)
World J Surg Oncol 22, 131 (2024). doi:10.1186/s12957-024-03406-5Témata: Male, Adult, 0301 basic medicine, RD1-811, Receptor, ErbB-3, MDM2 amplification, Coamplification, 03 medical and health sciences, 0302 clinical medicine, HER3, Biomarkers, Tumor, Humans, Molecular Targeted Therapy, ERBB3, RC254-282, In Situ Hybridization, Fluorescence, Aged, Research, Gene Amplification, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Proto-Oncogene Proteins c-mdm2, Liposarcoma, Middle Aged, Prognosis, 3. Good health, DDIT3, Aged [MeSH], Liposarcoma/genetics [MeSH], Gene Amplification [MeSH], Proto-Oncogene Proteins c-mdm2/genetics [MeSH], Proto-Oncogene Proteins c-mdm2/metabolism [MeSH], Male [MeSH], Molecular Targeted Therapy/methods [MeSH], Liposarcoma/pathology [MeSH], Female [MeSH], Fluoresence in situ hybridization (FISH) immunohistochemistry, Adult [MeSH], Humans [MeSH], Middle Aged [MeSH], Receptor, ErbB-3/metabolism [MeSH], Biomarkers, Tumor/metabolism [MeSH], Biomarkers, Tumor/genetics [MeSH], Prognosis [MeSH], Liposarcoma/metabolism [MeSH], Receptor, ErbB-3/genetics [MeSH], In Situ Hybridization, Fluorescence [MeSH], Surgery, Female
-
13
Autoři: a další
Zdroj: BMC Cancer
BMC Cancer, Vol 24, Iss 1, Pp 1-10 (2024)Témata: Male, Adult, 0301 basic medicine, Cancer therapy, Digestive System Neoplasms, Targeted therapy, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Biomarkers, Tumor, Humans, Female [MeSH], Mutation [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Adult [MeSH], Precision oncology, Humans [MeSH], Panel gene sequencing, Precision Medicine/methods [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Male [MeSH], Research, Biomarkers, Tumor/genetics [MeSH], Digestive System Neoplasms/therapy [MeSH], Young Adult [MeSH], Digestive System Neoplasms/pathology [MeSH], Molecular Targeted Therapy/methods [MeSH], Digestive System Neoplasms/genetics [MeSH], Molecular Targeted Therapy, Precision Medicine, RC254-282, Retrospective Studies, Aged, Aged, 80 and over, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, 3. Good health, Mutation, Female
-
14
Autoři: a další
Přispěvatelé: a další
Témata: Biomarkers, Tumor/genetics, Brain Neoplasms/genetics, Clinical Trials as Topic, Glioblastoma/genetics, Humans, Molecular Targeted Therapy/methods, Neoplasm Recurrence, Local/genetics, Journal Article
Popis souboru: application/pdf
Dostupnost: https://dspace.library.uu.nl/handle/1874/456368
-
15
Autoři:
Zdroj: European Journal of Cancer. 159:56-59
Témata: Medical Oncology / methods, Neoplasms / therapy, Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Waterfall plot, Iceberg plot, Oncology and carcinogenesis, Spider plot, Swimmer plot, Medical Oncology, 3. Good health, Graphical representations in oncology, 03 medical and health sciences, 0302 clinical medicine, Neoplasms, Public Health and Health Services, Statistics in oncology, Computer Graphics, Humans, Oncology & Carcinogenesis, Molecular Targeted Therapy / methods, Molecular Targeted Therapy, Sequence-directed therapy, Cancer
Popis souboru: application/pdf
Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/34736043
https://www.ncbi.nlm.nih.gov/pubmed/34736043
https://pubmed.ncbi.nlm.nih.gov/34736043/
https://www.sciencedirect.com/science/article/pii/S0959804921011345
https://archive-ouverte.unige.ch/unige:168791
https://doi.org/10.1016/j.ejca.2021.09.034
https://escholarship.org/uc/item/7658b4nm -
16
Autoři:
Zdroj: Diabetologia
Diabetologia 64, 1461-1479 (2021)Témata: Blood Glucose, 0301 basic medicine, 0303 health sciences, Receptors, Cytoplasmic and Nuclear, Farnesoid X Receptor Agonists, Fibrosis, Hepatokines, Incretins, Insulin Resistance, Non-alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis, Peroxisome Proliferator-activated Receptor (ppar) Agonists, Review, Sglt2 Inhibitors, Lipid Metabolism, 3. Good health, 03 medical and health sciences, Hypoglycemic Agents/pharmacology [MeSH], Incretins/pharmacology [MeSH], Insulin resistance, Farnesoid X receptor agonists, Liver/metabolism [MeSH], Liver/drug effects [MeSH], Non-alcoholic Fatty Liver Disease/complications [MeSH], Diabetes Mellitus, Type 2/drug therapy [MeSH], Receptors, Cytoplasmic and Nuclear/metabolism [MeSH], Non-alcoholic steatohepatitis, Hypoglycemic Agents/therapeutic use [MeSH], Pharmaceutical Preparations/classification [MeSH], Incretins/therapeutic use [MeSH], Molecular Targeted Therapy/methods [MeSH], SGLT2 inhibitors, Non-alcoholic Fatty Liver Disease/drug therapy [MeSH], Diabetes Mellitus, Type 2/complications [MeSH], Humans [MeSH], Non-alcoholic Fatty Liver Disease/metabolism [MeSH], Animals [MeSH], Lipid Metabolism/drug effects [MeSH], Non-alcoholic fatty liver disease, Blood Glucose/metabolism [MeSH], Insulin Resistance/physiology [MeSH], Diabetes Mellitus, Type 2/metabolism [MeSH], Blood Glucose/drug effects [MeSH], Peroxisome proliferator-activated receptor (PPAR) agonists, Receptors, Cytoplasmic and Nuclear/agonists [MeSH], Diabetes Mellitus, Type 2, Liver, Pharmaceutical Preparations, Animals, Humans, Hypoglycemic Agents, Molecular Targeted Therapy
Popis souboru: application/pdf
Přístupová URL adresa: https://link.springer.com/content/pdf/10.1007/s00125-021-05442-2.pdf
https://pubmed.ncbi.nlm.nih.gov/33877366
https://link.springer.com/article/10.1007/s00125-021-05442-2
https://pubmed.ncbi.nlm.nih.gov/33877366/
https://link.springer.com/content/pdf/10.1007/s00125-021-05442-2.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187191/
https://europepmc.org/article/PMC/PMC8187191
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=61827
https://repository.publisso.de/resource/frl:6451920 -
17
Autoři: a další
Přispěvatelé: a další
Zdroj: Chemical Society Reviews
Témata: 0301 basic medicine, Small Molecule Libraries/chemistry, Antiviral Agents/chemistry, SARS-CoV-2/chemistry, COVID-19/drug therapy, Antiviral Agents, Small Molecule Libraries, 03 medical and health sciences, SDG 3 - Good Health and Well-being, RA0421, RA0421 Public health. Hygiene. Preventive Medicine, Drug Discovery, Humans, QD, Drug Discovery/methods, Molecular Targeted Therapy, Pandemics/prevention & control, Pandemics, CVG-1725-2020, Nucleic Acid Synthesis Inhibitors, QR355, Biological Products, 0303 health sciences, Biological Products/chemistry, SARS-CoV-2, COVID-19, General Chemistry, QD Chemistry, Medical Research Council (MRC), MR/Vo28464/1, COVID-19 Drug Treatment, 3. Good health, Molecular Docking Simulation, Coronavirus Protease Inhibitors, Nucleic Acid Synthesis Inhibitors/chemistry, RNA, RNA, Viral, Other, QR355 Virology, Coronavirus Protease Inhibitors/chemistry, Molecular Targeted Therapy/methods, Viral/antagonists & inhibitors
Popis souboru: pdf; application/pdf
Přístupová URL adresa: https://pubs.rsc.org/en/content/articlepdf/2021/cs/d0cs01118e
https://pubmed.ncbi.nlm.nih.gov/33524090
https://research-repository.st-andrews.ac.uk/bitstream/10023/21355/1/Adamson_2021_Antiviral_drug_discovery_ChemSocRev_CC.pdf
https://pubs.rsc.org/en/content/articlelanding/2021/cs/d0cs01118e#!
https://research-repository.st-andrews.ac.uk/handle/10023/21355
https://jglobal.jst.go.jp/detail?JGLOBAL_ID=202102284968928785
https://pubs.rsc.org/en/content/articlepdf/2021/cs/d0cs01118e
https://covid19.elsevierpure.com/en/publications/antiviral-drug-discovery-preparing-for-the-next-pandemic -
18
Autoři: a další
Zdroj: Revue medicale suisse, vol. 21, no. 918, pp. 1023-1030
Témata: Humans, Immune Checkpoint Inhibitors/adverse effects, Immune Checkpoint Inhibitors/administration & dosage, Lung Neoplasms/drug therapy, Lung Neoplasms/therapy, Immunoconjugates/adverse effects, Immunoconjugates/administration & dosage, Molecular Targeted Therapy/adverse effects, Molecular Targeted Therapy/methods, Antineoplastic Agents/adverse effects
Popis souboru: application/pdf
-
19
Autoři:
Zdroj: Buch, M H, Eyre, S & McGonagle, D 2021, 'Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis', Nature Reviews. Rheumatology, vol. 17, no. 1, pp. 17-33. https://doi.org/10.1038/s41584-020-00541-7
Témata: Epigenomics, Drug Resistance, Antirheumatic Agents/adverse effects, Inflammation/diagnosis, Arthritis, Rheumatoid, 03 medical and health sciences, Arthritis, Rheumatoid/classification, Sex Factors, 0302 clinical medicine, Tumor Necrosis Factor Inhibitors/therapeutic use, Humans, Janus Kinase Inhibitors, Molecular Targeted Therapy, Treatment Failure, Inflammation, Synovitis, Janus Kinase Inhibitors/therapeutic use, Synovitis/diagnosis, Epigenomics/methods, Genomics, Receptors, Interleukin-6, 3. Good health, Phenotype, Antirheumatic Agents, Receptors, Interleukin-6/antagonists & inhibitors, Tumor Necrosis Factor Inhibitors, Molecular Targeted Therapy/methods
-
20
Autoři:
Zdroj: Mol Diagn Ther
Témata: 0301 basic medicine, Clinical Trials as Topic, 0303 health sciences, Disease Management, Gene Expression, Review Article, Genetic Therapy, Combined Modality Therapy, Genetic Predisposition to Disease [MeSH], Mutation [MeSH], Gene Targeting [MeSH], Humans [MeSH], Treatment Outcome [MeSH], Molecular Medicine, Gene Expression [MeSH], Disease Susceptibility [MeSH], Disease Management [MeSH], Epidermolysis Bullosa/diagnosis [MeSH], Genetic Therapy [MeSH], Cancer Research, Clinical Trials as Topic [MeSH], Epidermolysis Bullosa/therapy [MeSH], Laboratory Medicine, Combined Modality Therapy [MeSH], Biomarkers [MeSH], Epidermolysis Bullosa/etiology [MeSH], Molecular Targeted Therapy/methods [MeSH], Drug Development [MeSH], Human Genetics, Pharmacotherapy, 3. Good health, 03 medical and health sciences, Treatment Outcome, Drug Development, Gene Targeting, Mutation, Humans, Genetic Predisposition to Disease, Disease Susceptibility, Molecular Targeted Therapy, Epidermolysis Bullosa, Biomarkers
Popis souboru: pdf
Přístupová URL adresa: https://link.springer.com/content/pdf/10.1007/s40291-020-00466-7.pdf
https://pubmed.ncbi.nlm.nih.gov/32328988
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264085
https://link.springer.com/content/pdf/10.1007/s40291-020-00466-7.pdf
https://link.springer.com/article/10.1007/s40291-020-00466-7
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264085
https://pubmed.ncbi.nlm.nih.gov/32328988/
https://repository.publisso.de/resource/frl:6465115
Full Text 
Full Text Finder 
Nájsť tento článok vo Web of Science